Skip to main content
Bioton S.A. logo

Bioton S.A. — Investor Relations & Filings

Ticker · BIO ISIN · PLBIOTN00029 LEI · 259400I5R1L3OPCGII81 WAR Manufacturing
Filings indexed 697 across all filing types
Latest filing 2022-08-31 Audit Report / Informat…
Country PL Poland
Listing WAR BIO

About Bioton S.A.

https://bioton.com/en/

Bioton S.A. is a biotechnology company focused on providing comprehensive solutions for diabetes care. The company's core activity is the development and production of recombinant human insulin, positioning it as a significant commercial manufacturer globally. Its operations cover the full biotechnological process, from DNA research and development to the manufacturing and marketing of finished medicinal products. The product portfolio is centered on various forms of insulin and is complemented by modern automatic injection systems designed to facilitate effective diabetes treatment for patients.

Recent filings

Filing Released Lang Actions
Raport biegłego rewidenta 1H 2022 skonsolidowane
Audit Report / Information Classification · 98% confidence The document is titled "RAPORT NIEZALEŻNEGO BIEGŁEGO REWIDENTA Z PRZEGLĄDU" (Independent Auditor's Review Report) concerning a "skróconego śródrocznego skonsolidowanego sprawozdania finansowego" (condensed interim consolidated financial statements) for the period ending 30.06.2022. This clearly indicates an audit or review report related to interim financial data. The definition for Audit Report / Information (AR) covers 'Standalone audit reports, applied accounting principles, and results of internal or regulatory stress tests (excluding full Annual Reports)'. Since this is a review report on interim financial statements, AR is the most appropriate classification, distinguishing it from the full Annual Report (10-K) or a general Earnings Release (ER). H1 2022
2022-08-31 Polish
Sprawozdanie Zarządu 1H 2022
Interim / Quarterly Report Classification · 100% confidence The document is a semi-annual report (półroczne sprawozdanie finansowe) for the period 01.01.2022 to 30.06.2022. It contains detailed financial statements, including consolidated and standalone balance sheets, income statements, and cash flow statements, as well as management commentary. This fits the definition of an Interim/Quarterly Report (IR). H1 2022
2022-08-31 Polish
Sprawozdanie finansowe 1H 2022 jednostkowe
Interim / Quarterly Report Classification · 100% confidence The document is a 'Skrócone śródroczne jednostkowe sprawozdanie finansowe' (Condensed Interim Separate Financial Statement) for the period ending June 30, 2022. It contains comprehensive financial statements (Balance Sheet, Income Statement, Cash Flow, etc.) and detailed notes, which aligns with the definition of an Interim/Quarterly Report (IR). It is not an announcement (RPA) as it contains the full financial data. H1 2022
2022-08-31 Polish
Sprawozdanie finansowe 1H 2022 skonsolidowane
Interim / Quarterly Report Classification · 100% confidence The document is a 'Skrócone śródroczne skonsolidowane sprawozdanie finansowe' (Condensed Interim Consolidated Financial Report) for the period ending June 30, 2022. It contains comprehensive financial statements (balance sheet, income statement, cash flow, etc.) and detailed notes, which aligns perfectly with the definition of an Interim/Quarterly Report (IR). It is not an announcement (RPA) as it contains the full financial data and analysis. H1 2022
2022-08-31 Polish
Spłata kredytu udzielonego przez Bank of China - Content (PL)
Capital/Financing Update Classification · 98% confidence The document text, written in Polish, announces the early repayment (przedterminowej spłaty) of a loan (kredytu) totaling EUR 1,804,632.50, which was originally established under a Senior Facility Agreement. It also mentions securing a new loan of PLN 15,000,000.00 from BNP Paribas Bank Polska S.A. This action directly relates to the company's financing activities and capital structure changes (repaying old debt and taking new debt). This aligns perfectly with the definition for Capital/Financing Update (CAP). The document is a specific announcement about a financing event, not a general regulatory filing (RNS) or a report announcement (RPA), given its specific content.
2022-08-26 Polish
Odmowa przyjęcia do rozpoznania przez Sąd Najwyższy Skargi Kasacyjnej AIS INVESTMENT 2 SP. Z O.O. - Content (PL)
Legal Proceedings Report Classification · 98% confidence The document text is very short (834 characters) and describes a specific legal development: the Supreme Court's refusal to hear an appeal (skarga kasacyjna) regarding a shareholder resolution concerning the sale of SciGen Ltd. This is a notification about a significant legal proceeding outcome. It is not a full report (like 10-K or IR), nor is it a general announcement of a report (RPA). It specifically details the status of a lawsuit/legal matter. Therefore, the most appropriate classification is Legal Proceedings Report (LTR).
2022-08-19 Polish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.